A molecular diagnostics company developed a blood test to support treatment selection for patients with advanced non-small cell lung cancer (NSCLC).

A biopharma company was conducting a Phase III study to assess the safety and effectiveness of a new COVID-19 vaccine. They needed to identify and connect to real-world…

Datavant technology has been vetted and validated through hundreds of security and compliance assessments with the industry’s most stringent organizations.

As a greater number of drugs are distributed through specialty channels, it is difficult to gain deep insights into the patient journey. Single data sources provide limited visibility…

A top 20 pharma company noticed that a significant portion of patients who were on an infusion therapy had stopped treatment. This happened despite patients receiving support through…

A major pharma company had developed a treatment for a rare condition. However, two years after launch, the drug’s sales were far below expectations. Finding eligible patients for…

Address the need for highly accurate privacy-preserving record linkage and patient matching solutions to unlock research and innovation.

Connecting data at the patient level is critical in gaining a deep, longitudinal view of how different interventions and policies can affect patient outcomes. The following peer-reviewed articles…